XML 21 R8.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Jan. 31, 2017
Jan. 31, 2016
Jan. 31, 2015
CASH FLOWS FROM OPERATING ACTIVITIES      
Net loss $ (245,066) $ (213,752) $ (183,231)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 50,203 32,254 15,392
Stock-based compensation expense 116,668 58,225 25,399
Contribution of common stock to the Pure Good Foundation 0 11,900 0
Other 1,584 (1,093) 277
Changes in operating assets and liabilities:      
Accounts receivable, net (44,049) (67,292) (44,197)
Inventory (3,776) 1,481 (13,713)
Deferred commissions (740) (13,021) (9,838)
Prepaid expenses and other current assets (6,133) (8,704) (6,550)
Accounts payable 10,644 24,901 3,474
Accrued compensation and other liabilities 19,381 24,710 12,450
Deferred revenue 86,922 142,535 56,842
Net cash used in operating activities (14,362) (7,856) (143,695)
CASH FLOWS FROM INVESTING ACTIVITIES      
Purchases of property and equipment (76,773) (39,355) (42,227)
Purchase of intangible assets (1,000) 0 (9,125)
Purchases of marketable securities (526,717) 0 0
Sales of marketable securities 114,354 0 0
Maturities of marketable securities 48,513 0 0
Net increase in restricted cash (5,600) (2,485) (1,613)
Net cash used in investing activities (447,223) (41,840) (52,965)
CASH FLOWS FROM FINANCING ACTIVITIES      
Proceeds from initial public offering, net of issuance costs 0 459,425 0
Proceeds from issuance of convertible preferred stock, net of issuance costs 0 0 280,970
Net proceeds from exercise of stock options, including proceeds from repayment of promissory notes 14,912 6,008 7,665
Proceeds from issuance of common stock under employee stock purchase plan 25,606 0 0
Repurchase of common stock in connection with tender offer 0 0 (30,120)
Payments of deferred offering costs 0 (3,702) (33)
Net cash provided by financing activities 40,518 461,731 258,482
Net increase in cash and cash equivalents (421,067) 412,035 61,822
Cash and cash equivalents, beginning of period 604,742 192,707 130,885
Cash and cash equivalents, end of period 183,675 604,742 192,707
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION      
Cash paid for income taxes 2,866 1,118 429
SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING INFORMATION      
Conversion of convertible preferred stock to common stock upon initial public offering 0 543,940 0
Property and equipment purchased but not yet paid 7,414 6,212 1,323
Vesting of early exercised stock options 3,399 1,725 1,162
Cashless exercise of stock options during tender offer 0 0 2,057
Unpaid deferred offering costs $ 0 $ 546 $ 55